Suppr超能文献

相似文献

1
Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.
Am J Hum Genet. 2007 Nov;81(5):884-94. doi: 10.1086/521986. Epub 2007 Sep 7.
2
Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
Am J Hum Genet. 2004 Dec;75(6):1124-30. doi: 10.1086/426035. Epub 2004 Oct 4.
6
Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD).
J Med Genet. 2020 Feb;57(2):109-120. doi: 10.1136/jmedgenet-2019-106078. Epub 2019 Sep 10.
8
Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy.
Neuromuscul Disord. 2005 Jul;15(7):471-5. doi: 10.1016/j.nmd.2005.03.005.
10
D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.
Neurology. 2003 Jul 22;61(2):178-83. doi: 10.1212/01.wnl.0000078889.51444.81.

引用本文的文献

1
A systemically deliverable lipid-conjugated siRNA targeting DUX4 as an facioscapulohumeral muscular dystrophy therapeutic.
Mol Ther Methods Clin Dev. 2025 Jun 16;33(3):101513. doi: 10.1016/j.omtm.2025.101513. eCollection 2025 Sep 11.
2
Deciphering Facioscapulohumeral Dystrophy in the clinical trials era: where are we now?
Acta Myol. 2025 Mar;44(1):2-10. doi: 10.36185/2532-1900-1047.
3
The distribution of D4Z4 repeats in China and direct prenatal diagnosis of FSHD by optical genome mapping.
Orphanet J Rare Dis. 2025 Feb 11;20(1):67. doi: 10.1186/s13023-025-03591-w.
4
Facioscapulohumeral muscular dystrophy type 1 combined with becker muscular dystrophy: a family case report.
Front Genet. 2025 Jan 7;15:1522203. doi: 10.3389/fgene.2024.1522203. eCollection 2024.
7
Facioscapulohumeral Dystrophy: Molecular Basis and Therapeutic Opportunities.
Cold Spring Harb Perspect Biol. 2025 Apr 1;17(4):a041492. doi: 10.1101/cshperspect.a041492.
8
SMCHD1 activates the expression of genes required for the expansion of human myoblasts.
Nucleic Acids Res. 2024 Sep 9;52(16):9450-9462. doi: 10.1093/nar/gkae600.
9
French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD).
J Neurol. 2024 Sep;271(9):5778-5803. doi: 10.1007/s00415-024-12538-3. Epub 2024 Jul 2.
10
DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis.
Sci Adv. 2024 May 31;10(22):eadn7732. doi: 10.1126/sciadv.adn7732. Epub 2024 May 29.

本文引用的文献

2
Online Mendelian Inheritance in Man 'OMIM'.
Indian J Dermatol Venereol Leprol. 2003 Nov-Dec;69(6):423-4.
3
RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA.
Biochim Biophys Acta. 2007 Jan;1769(1):29-40. doi: 10.1016/j.bbaexp.2006.11.006. Epub 2006 Nov 22.
4
Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts.
Proc Natl Acad Sci U S A. 2006 May 2;103(18):6982-7. doi: 10.1073/pnas.0511235103. Epub 2006 Apr 21.
5
Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
Am J Hum Genet. 2004 Dec;75(6):1124-30. doi: 10.1086/426035. Epub 2004 Oct 4.
6
Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease?
Hum Mol Genet. 2004 Sep 1;13(17):1857-71. doi: 10.1093/hmg/ddh205. Epub 2004 Jul 6.
8
Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy.
Nat Genet. 2003 Dec;35(4):315-7. doi: 10.1038/ng1262. Epub 2003 Nov 23.
9
10
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
Hum Mol Genet. 2003 Nov 15;12(22):2895-907. doi: 10.1093/hmg/ddg327. Epub 2003 Sep 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验